Friligkou Eleni, Koller Dora, Pathak Gita A, Miller Edward J, Lampert Rachel, Stein Murray B, Polimanti Renato
medRxiv. 2023 Aug 4:2023.08.02.23293170. doi: 10.1101/2023.08.02.23293170.
Anxiety disorders are associated with decreased heart rate variability (HRV), but the underlying mechanisms remain elusive.
We selected individuals with whole-genome sequencing, Fitbit, and electronic health record data (N=920; 61,333 data points) from the All of Us Research Program. Anxiety PRS were derived with PRS-CS after meta-analyzing anxiety genome-wide association studies from three major cohorts-UK Biobank, FinnGen, and the Million Veterans Program (N Total =364,550). The standard deviation of average RR intervals (SDANN) was calculated using five-minute average RR intervals over full 24-hour heart rate measurements. Antidepressant exposure was defined as an active antidepressant prescription at the time of the HRV measurement in the EHR. The associations of daily SDANN measurements with the anxiety PRS, antidepressant classes, and antidepressant substances were tested. Participants with lifetime diagnoses of cardiovascular disorders, diabetes mellitus, and major depression were excluded in sensitivity analyses. One-sample Mendelian randomization (MR) was employed to assess potential causal effect of anxiety on SDANN.
Anxiety PRS was independently associated with reduced SDANN (beta=-0.08; p=0.003). Of the eight antidepressant medications and four classes tested, venlafaxine (beta=-0.12, p=0.002) and bupropion (beta=-0.071, p=0.01), tricyclic antidepressants (beta=-0.177, p=0.0008), selective serotonin reuptake inhibitors (beta=-0.069; p=0.0008) and serotonin and norepinephrine reuptake inhibitors (beta=-0.16; p=2×10 ) were associated with decreased SDANN. One-sample MR indicated an inverse effect of anxiety on SDANN (beta=-2.22, p=0.03).
Anxiety and antidepressants are independently associated with decreased HRV, and anxiety appears to exert a causal effect on HRV. Our observational findings provide novel insights into the impact of anxiety on HRV.
焦虑症与心率变异性(HRV)降低有关,但其潜在机制仍不清楚。
我们从“我们所有人”研究计划中选择了具有全基因组测序、Fitbit和电子健康记录数据的个体(N = 920;61333个数据点)。在对来自三个主要队列——英国生物银行、芬兰基因研究和百万退伍军人计划(N总计 = 364550)的焦虑全基因组关联研究进行荟萃分析后,使用PRS-CS得出焦虑多基因风险评分(PRS)。使用24小时完整心率测量中五分钟的平均RR间期来计算平均RR间期的标准差(SDANN)。抗抑郁药暴露定义为在电子健康记录中进行HRV测量时的有效抗抑郁药处方。测试了每日SDANN测量值与焦虑PRS、抗抑郁药类别和抗抑郁药物质之间的关联。在敏感性分析中排除了有心血管疾病、糖尿病和重度抑郁症终生诊断的参与者。采用单样本孟德尔随机化(MR)来评估焦虑对SDANN的潜在因果效应。
焦虑PRS与降低的SDANN独立相关(β = -0.08;p = 0.003)。在测试的八种抗抑郁药物和四类药物中,文拉法辛(β = -0.12,p = 0.002)和安非他酮(β = -0.071,p = 0.01)、三环类抗抑郁药(β = -0.177,p = 0.0008)、选择性5-羟色胺再摄取抑制剂(β = -0.069;p = 0.0008)和5-羟色胺和去甲肾上腺素再摄取抑制剂(β = -0.16;p = 2×10 )与降低的SDANN相关。单样本MR表明焦虑对SDANN有反向效应(β = -2.22,p = 0.03)。
焦虑和抗抑郁药与降低的HRV独立相关,并且焦虑似乎对HRV有因果效应。我们的观察结果为焦虑对HRV的影响提供了新的见解。